Photo from wikipedia
Abstract: The current understanding on the clinical efficacy of Rho-associated protein kinase (ROCK) inhibitor for treating Fuchs endothelial corneal dystrophy is summarized to clarify whether the “off-label” ROCK-inhibitor eye-drop application… Click to show full abstract
Abstract: The current understanding on the clinical efficacy of Rho-associated protein kinase (ROCK) inhibitor for treating Fuchs endothelial corneal dystrophy is summarized to clarify whether the “off-label” ROCK-inhibitor eye-drop application are appropriate. ROCK-inhibitor eye drops may eventually be deemed a cutting-edge therapy for Fuchs endothelial corneal dystrophy patients with acute corneal endothelial defect.
Keywords:
inhibitor eye;
corneal dystrophy;
endothelial corneal;
inhibitor;
fuchs endothelial
Journal Title: Cornea
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Cornea
Year Published: 2021
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!